• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ISG posts strong growth, releases NT-based software

Article

ISG posts strong growth, releases NT-based softwareMedical imaging and PACS software developer ISG Technologies reported strong financial results for its 1998 fiscal third quarter. The company realized a 16% increase in revenue for the period

ISG posts strong growth, releases NT-based software

Medical imaging and PACS software developer ISG Technologies reported strong financial results for its 1998 fiscal third quarter. The company realized a 16% increase in revenue for the period (end-March).

Revenues for the quarter were $9.1 million (Canadian), compared with $7.8 million reported in the same period last year. Net income was $108,000, compared with a net loss of $354,000 in 1997. The firm attributed the quarterly revenue growth to sales of platforms, postprocessing workstation software licenses, and contract engineering activities.

In other ISG news, the Mississauga, Ontario-based company formally released version 3.0 of its VR line of PACS viewing software. ISG demonstrated the Windows NT-based version of the software at the 1997 Radiological Society of North America meeting (PNN 1/98).

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.